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Here we report what is to our knowledge the ﬁrst identiﬁed Japanese family aﬄicted by X-linked myopathy with excessive autophagy.
The index case is a 52-year-old man with almost 40 years of progressive proximal muscle weakness. High urinary b2 microglobulin,
normal serum b2 microglobulin, autophagic vacuoles with sarcolemmal features, and a hemizygous c.164–7T>G mutation in the
VMA21 gene were found. His two maternal uncles had similar clinicopathological ﬁndings. High urinary b2 microglobulin without
obvious renal dysfunction might result from decreased urine acidiﬁcation in the distal convoluted tubules caused by the VMA21 gene
mutation. These ﬁndings might prove to be useful as a preliminary marker suggestive of X-linked myopathy with excessive autophagy.
 2013 The Authors. Published by Elsevier B.V.
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X-linked myopathy with excessive autophagy (XMEA)
is a slowly progressive, inherited, autophagic, vacuolar
myopathy (AVM) deﬁned by proximal muscle weakness
of the extremities beginning in early childhood.
Clinically, there is no cardiac muscle involvement,
cognitive impairment, or other organ manifestation [1,2].0960-8966  2013 The Authors. Published by Elsevier B.V.
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Open access undeElectromyography (EMG) ﬁndings are characterized by
abundant myotonic and high-frequency discharges with
no clinical myotonia, even in clinically unaﬀected muscles
[2]. Muscle MRI has revealed fatty degeneration [2] and
muscle biopsy specimens have revealed so-called
autophagic vacuoles with sarcolemmal features (AVSFs)
by light microscopy and a multi-layered basal membrane
by electron microscopy [1–3]. AVSFs contain cell debris
(degenerating organelles, granular material, and
membrane whorls), which is also present between the
layers of the multiplied basal lamina, and both
compartments stain positively for acetylcholine esterase,
acid phosphatase and other lysosomal enzymes such as
lysosome-associated membrane protein 2 (LAMP2) [2,3].
Recent ﬁndings have revealed that vacuolar membrane
ATPase activity 21 (VMA21) is a causative gene of
XMEA [4].
VMA21 is one of the factors required for assembly of
the vacuolar (V-) ATPase V0 domain in the endoplasmicr CC BY-NC-SA license.
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V0 domain and directs assembly of the proteolipid ring and
subunit d of the V0 domain. A complex of other factors
stabilizes subunit a of the V0 domain and, along with the
remainder of the V0 complex, facilitates the assembly of
V-ATPase. VMA21 accompanies the V0 and V1 complex
to the Golgi apparatus, where it is released and then
recycled to the ER [5]. Lysosomal degradation by
V-ATPase requires a low pH; a pH that is too high
might decrease protein degradation in the autolysosomes
of XMEA patients, which might lead to up-regulation of
multivesicular body formation and exocytosis. V-ATPases
are also located at the plasma membrane of several types
of cells, which include renal intercalated cells in distal
tubules and collecting ducts, and osteoclasts in bone.
Dysfunction of V-ATPase may also cause renal
dysfunction and osteopetrosis [5].
XMEA families have been identiﬁed in Europe and
North America [2,4], but to our knowledge none has
been identiﬁed previously in Asia, in spite of previousFig. 1. (A) Pedigree of XMEA family. Shaded boxes represent aﬀected m
Unaﬀected family members exhibited no abnormalities during the course of t
MRI of bilateral thighs revealed atrophy and fatty degeneration of femoral mus
biopsies were performed for individuals II-7 and III-1. NE: not examined.reports of severe cases [6,7]. In this report, we describe a
Japanese XMEA family identiﬁed by examining and
interviewing an index patient, and suggest that the
elevation of urinary b2 microglobulin (b2 MG) may be a
useful preliminary marker suggestive of XMEA.
2. Case reports
The pedigree chart of the aﬄicted family is presented in
Fig. 1A.
2.1. Patient 1
The index case (III-1) had learned to walk normally, but
at the age of 6 years was unable to keep pace with his
companions while running. The muscle weakness had
progressed slowly, so that at age of 52 years he was still
ambulatory without assistance and able to work as a
medical laboratory technician. On presentation at age of
52 years, cardiac and respiratory functions were normal.embers. Symbols having diagonal lines represent decreased individuals.
heir medical examinations. (B) T2-weighted MRI and (C) fat suppression
cles, apart from the rectus femoris that was spared in both patients. Muscle
Fig. 2. Histological analysis of muscle biopsy specimens. Sections from individuals (A–F) III-1 and (H) II-7. (A) By hematoxylin and eosin staining, mild
variation in ﬁber size was observed. Many ﬁbers had vacuoles containing basophilic granules. (B) By modiﬁed Gomori trichrome staining, the vacuoles
contained red or purple material. The vacuoles displayed high non-speciﬁc enolase (C) and acetylcholine esterase (D) activity. (E) Acid phosphatase
activity in the vacuoles was variable and (F) the immunoreactivity against lysozyme was positive. (G) By electron micrography, the section from individual
III-1 contained many vacuoles surrounded by a single-layer membrane, in which debris was seen. A multilayered basal lamina along the sarcolemma was
observed. (H) The hematoxylin and eosin stained section revealed mild variation in ﬁber size and vacuoles in many ﬁbers. (I) By electron micrography, the
section from individual II-7 also contained many vacuoles surrounded by a single-layer membrane, in which debris was seen. A multilayered basal lamina
along the sarcolemma was observed. Immunohistochemical analysis revealed that the vacuoles observed in frozen sections from individual III-1 were
immunopositive for all sarcolemmal proteins assayed, including dystrophin (J) and merosin (M, P). (J–L) Dystrophin-positive vacuoles were also
immunopositive against LAMP2 (J). (M–O) Merosin-positive and VMA21-negative vacuoles (arrow) were scattered. (P–R) Sections from individuals with
various neuromuscular diseases (see text) reveal AVSFs having strong immunoreactivity for VMA21. Scale bars: (A–F, H, J–R) 50 lm; (G, I) 1 lm.
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Fig. 3. Western blot and gene analysis. (A) The sarkosyl-soluble fractions
and HEK293T lysate (sc-112091, Santa Cruz, CA, USA) were subjected to
SDS–polyacrylamide gel electrophoresis followed by immunoblotting with
anti-VMA21 or anti-alpha tubulin (loading control) antibodies. (B)
VMA21 gene analysis showed a hemizygous c.164–7T>G VMA21
mutation.
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kinase (CK) (450 IU/l; normal range 6210 IU/l) and
urinary b2 MG (1.51 lg/ml; normal range 60.20 lg/ml).
Serum b2 MG (0.90 lg/ml) was within the normal range
(61.20 lg/ml). The urinary pH was between 5.5 and 6.0
(normal range 66.5). Chest X-ray (CXR) revealed no
bone abnormalities and bone mineral density was
normal. Needle EMG showed abundant myotonic
discharges in the muscles. Muscle MRI revealed adipose
degeneration (Fig. 1B and C). Muscle biopsy from the
left biceps brachii was performed at age 52; light
microscopic examination revealed muscle ﬁbers with
vacuoles containing delicate basophilic debris (Fig. 2A
and B). The vacuoles had the characteristic high non-
speciﬁc enolase and acetylcholine esterase activity of
AVSFs, consistent with previous reports (Fig. 2C and D)
[2,3]. The AVSFs had high acid phosphatase (Fig. 2E)
and lysozyme (Fig. 2F) activity, consistent with a
previous report [1]. Electron microscopy showed that the
AVSFs were surrounded by a single membrane, and that
there were vacuolated ﬁbers containing granular debris
between redundant folds of the basal lamina as well as in
the AVSFs (Fig. 2G). Immunohistochemical analysis
conﬁrmed that the AVSFs were immunopositive for
lysozyme, all sarcolemmal proteins assayed, including
dystrophin (Fig. 2J) and merosin (Fig. 2M), and LAMP2
(Fig. 2K), consistent with a previous report [3].
Importantly, double immunoﬂuorescence revealed that
the AVSFs were less immunopositive for VMA21 than
they were for merosin, and areas of reduced
VMA21-immunoreactivity were scattered throughout the
AVSFs (Fig. 2M–O). On the other hand, the AVSFs
observed in cases having other diseases had VMA21
immunoreactivity (Fig. 2 P–R).
To assess the specimens, samples were subjected to 20%
SDS–polyacrylamide gel electrophoreses and then
electrotransferred onto a nitrocellulose membrane
(Schleicher & Schuell, Dassel, Germany), as previously
described [8]. In sarkosyl-soluble fractions of the muscle
biopsy specimens, we observed a single 15-kDa band,
which is in accordance with the previously reported
molecular weight of VMA21 [4]. The muscle biopsy
specimen of individual III-1 contained a weaker VMA21
band than did that of an age-matched healthy control
(Fig. 3A). Genetic analysis of VMA21 was performed for
III-1 after informed consent was provided as a part of
the diagnostic procedure; a hemizygous mutation was
revealed (c. 164–7T>G) (Fig. 3B).
2.2. Patient 2
This individual (II-7) is a maternal uncle of the index
patient, and a younger brother of Patient 3 (II-4). He
learned to walk normally and exhibited normal
intelligence. However, muscle weakness became evident
during his childhood. He could not walk without support
but was able to work as a taxi driver. He was examinedat 43 years of age. At that time, cardiac function was
normal but restrictive respiratory impairment was
observed because of pulmonary emphysema due to heavy
smoking (Brinkman Index [9] = 810). His laboratory data
included elevations of serum CK (300 IU/l) and urinary
b2 MG (0.90 lg/ml). Serum b2 MG was normal (0.51 lg/
ml). The urinary pH was between 5.5 and 6.0. CXR
revealed a ﬂattened diaphragm due to pulmonary
emphysema but no bone abnormalities. Needle EMG
disclosed abundant myotonic discharges. These ﬁndings
prompted us to perform a muscle biopsy. Examination of
formalin-ﬁxed sections by light microscopy revealed
AVSFs (Fig. 2G). Electron microscopy revealed that the
AVSFs were surrounded by a single membrane, and that
there were vacuolated ﬁbers containing granular debris
between redundant folds of the basal lamina as well as in
the AVSFs (Fig. 2H). This patient died of pulmonary
emphysema during his ﬁfth decade.2.3. Patient 3
This individual (II-4) is a maternal uncle of III-1 and an
older brother of II-7. He learned to walk normally and
exhibited normal intelligence. Muscle weakness became
evident during his childhood. He was examined at age 47,
when II-7 was examined. He was still ambulatory without
assistance and was able to work as a farmer. Cardiac
involvement was not observed. His laboratory data
included elevation of urinary b2 MG (2.00 lg/ml). Serum
Table 1
Demographic and clinical features of Japanese XMEA patients.
Patient III-1 II-7 II-4
Age at onset Childhood Childhood Childhood
Gender Male Male Male
Symptom at onset Lower muscle weakness Lower muscle weakness Lower muscle weakness
Progression Very slow Slow Very slow
Cognitive symptom None None None
Other clinical features None Pulmonary emphysema Pulmonary emphysema
Serum CK (IU/l; normal 6 210 IU/l) 450 300 N.E.
Serum b2 microglobulin (lg/ml; normal 6 1.20 lg/ml) 0.90 0.51 1.10
Urinary b2 microglobulin (lg/ml; normal 6 0.20 lg/ml) 1.51 0.90 2.00
Age at biopsy 52 43 N.E.
Muscle biopsy Left biceps brachii muscle Left biceps brachii muscle N.E.
Cause of death Alive Pulmonary emphysema Choking to death
Genetic analysis c.164–7T>G in VMA21 Unavailable Unavailable
CK: creatine kinase, N.E.: not examined.
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between 5.5 and 6.0. EMG showed abundant myotonic
discharges. CXR revealed no bone abnormalities. This
patient choked to death during his ﬁfth decade.
Other family members have never experienced
symptoms of muscle disease. II-9 has been receiving
treatment for chronic glomerulonephritis and renal cell
carcinoma for 10 years. Table 1 presents the clinical
features, including urinary and serum b2 MG, of patients
III-1, II-4, II-7, and II-9.
In addition, 45 patients with Becker muscular
dystrophy, polymyositis, sporadic inclusion body myositis,
distal myopathy with rimmed vacuoles or late-onset
Pompe disease were examined. Their laboratory data
included normal levels of urinary and serum b2 MG.
3. Discussion
XMEA is a slowly progressive inherited AVM
characterized pathologically by membrane-bound
sarcoplasmic vacuoles [1,2]. XMEA is caused by
hypomorphic alleles of the VMA21 gene, which is an
essential assembly chaperone of the vacuolar ATPase
(V-ATPase), the principal mammalian proton pump
complex [4]. The patients presented here had proximal
muscle weakness with fatty degeneration, and abundant
myotonic and high frequency discharges on EMG, which
are common among XMEA patients. We diagnosed
XMEA using pathological ﬁndings, western blot analysis,
and VMA21 gene analysis, which revealed the same
mutation found in a previously-reported French family [4].
VMA21 is one of the assembly factors of V-ATPase’s V0
domain in the endoplasmic reticulum (ER) [5]. VMA21
interacts with subunit c0 of V0 domain and directs
assembly of the proteolipid ring and subunit d of V0
domain. VMA21 accompanies the V0 and V1 complex to
the Golgi, where it is released and then recycled to the
ER [5]. Hemizygous mutation of VMA21 causes to
decrease V-ATPase and raise lysosomal pH. This might
decrease protein degradation in the autolysosomes ofXMEA patients, which might lead to up-regulation of
multivesicular body formation and exocytosis. V-ATPases
is also located at the plasma membrane of several types
of cells, which include renal intercalated cells in distal
tubule and collecting duct, and osteoclasts in bone, so
dysfunction of V-ATPases may also cause to renal
dysfunction, osteopetrosis [5].
The current XMEA patients had increased urinary, and
normal serum, b2 MG, unlike non-aﬀected family members
and patients with other neuromuscular disorders. In
addition, other laboratory data indicated that these
XMEA patients had normal renal function. b2 MG is
secreted into the urine in the renal glomerulus, and 99%
of secreted b2 MG is reabsorbed in the proximal
convoluted tubules [10]. Increased urinary b2 MG is
indicative either of increased serum b2 MG or
dysfunction of the proximal convoluted tubules. Serum
b2 MG is increased in patients with malignant tumors,
autoimmune disease, infection (including with hepatitis B
virus, infectious mononucleosis, and human
immunodeﬁciency virus), or glomerular dysfunction
[10,11]. All current aﬀected family members were free
from malignant tumors, autoimmune disease, and
infection, so in these cases, the increased urinary b2 MG
may have been attributed to dysfunction of the proximal
convoluted tubules; however, other markers of renal
function suggested that this was unlikely. b2 MG has
been widely studied in clinical settings, but its instability
in urine poses a major problem [12]. b2 MG is unstable
in urine at room temperature when the pH is less than
5.5, and appreciable loss of b2 MG occurs at body
temperature if the pH is less than 6.0 [10]. Urine is
acidiﬁed in the distal convoluted tubules in association
with acid–base homeostasis by Na+ uptake depending on
the Na+/H+ exchange in intercalated cells, which regulate
acid–base homeostasis by V-ATPases [13]. Elevated
urinary b2 MG without obvious renal dysfunction in
XMEA patients could be due to less urinary acidiﬁcation
in the distal convoluted tubules caused by decreased
V-ATPase, which might be concomitant with dysfunction
916 T. Kurashige et al. / Neuromuscular Disorders 23 (2013) 911–916of VMA21. Therefore, elevated urinary b2 MG in the
absence of obvious renal dysfunction may suggest
XMEA, and these ﬁndings may potentially be useful as a
preliminary marker suggestive of this condition.
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